In Vitro Diagnostics Industry Growth Analysis and Forecasts To 2021 In Vitro Diagnostics Industry: China Market Trend | Page 2

In Vitro Diagnostics Market Size, Application, Regional Outlook, Competitive
Strategies and Forecasts to 2021
In–Vitro Diagnostics(IVD) Market in China has been growing rapidly in the past few years and is expected
to grow steadily in the next few years, with major growth potential in segments such as infectious disease
testing, chronic disease testing and diagnosis in early stages of disease.
Company Coverage of China In Vitro Diagnostics Market: Mindray Medical International Limited, Shanghai
Fosun Pharmaceutical Group, Mingyuan Medicare, Da An Gene Co. Ltd., Shanghai Kehua Bio–Engineering
Co. Ltd., Zhejiang D.a. Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed
Diagnostics Center Co. Ltd., Kindstar Global, BGI – Shenzhen, OriGene Technologies.
Some of the major factors driving the growth of this market are the rising incidences of chronic lifestyle
diseases, public health awareness, growing aging population, demand of tests in rural areas stimulated by
the healthcare reform plan, increasing demand from the middle class for high–end products and an
increase in the number of private hospitals and independent testing laboratories.
China IVD Market: Segment wise Outlook:
Immunoassay has emerged as a significant rapidly growing market segment in China IVD market.
Immunoassay test controls nearly XX% market share by the year 2021. Other segments such as Clinical
Chemistry, Molecular testing and POCT are poised to be remarkable expansion in the near future. Growing
demand for infectious disease testing, chronic disease testing and diagnosis in early stages of disease will
usher the China IVD market.
Complete report available at http://www.marketreportsonline.com/496440.html